“Bone Grafts and Substitutes Market Report is set to have rapid growth due to the factors, such as High awareness regarding the commercially available products, higher healthcare expenditure, and availability of advanced healthcare infrastructure at global, regional and national level, influencing the industry trends in each of the sub-segments from 2019 to 2029”, says Visiongain Report

04 September 2019
Pharma

Visiongain has launched a new pharma report Bone Grafts and Substitutes Market Report: By Material Type (Natural, Synthetic), By Application Type (Spinal Fusion, Craniomaxillofacial, Long Bone), By Region, And Segment Forecasts

Bone Grafts and substitutes are broadly utilized in orthopedic medical procedures for various applications. Rising instances of orthopedic issues due to weakened bones is forecasted to have higher demand in the coming future, projected from 2019-2029.

According to the United Nations Department of Economic and Social Affairs, Population Division, the number of people over the age of 60 was 841 million in 2013 and is expected to reach 2 billion in 2050. Therefore, the number of orthopedic surgeries it should increase with an increasing geriatric population that is more prone to orthopedic disorders. Therefore, it is expected that the market will see significant demand during the forecast period.

However, the risk of disease transmission and the immune response are the main factors that hinder market growth. Furthermore, the high cost of advanced products and the rigorous regulatory process involved further limit market development. Furthermore, the ethical issues associated with bone harvesting limit market growth in some regions.

The market is divided into global bone graft segments, replacing market reports based on material, application, and region.

Major applications include craniofacial, dentistry, feet and ankles, joint reconstruction, long bones, and spinal fixation. Improved reimbursement scope and the presence of a large elderly patient population are some of the factors that support market growth.

Leading companies featured in the report include: DePuy Synthes; Medtronic PLC; Nuvasive, Inc.; Orthofix Holdings, Inc.; Wright Medical Group N.V.; AlloSource, Inc.; and Stryker Corp.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 207 336 6100.

About Visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Plasma Therapy Market Report 2021-2031

The market is forecasted for the next ten years based on market growth within each segment of the blood plasma products. The report study aims to explore the market drivers, restraints and also market opportunities facing blood plasma product stakeholders in different geographic areas.

26 November 2020

Read

Visiongain Publishes Precision Cancer Diagnostic Test Market Report 2021-2031

Molecular diagnostics are rapidly transforming drug development and patient selection: trials with biomarkers have higher success rates than those without, and combining patients with a proven biomarker allows efficient trials to be conducted in rare cancers.

26 November 2020

Read

Visiongain Publishes Top 50 Biosimilar Drug Manufacturers 2021

Growing demand for cost-effective drugs; rising prevalence of chronic diseases; mounting investment in drug R&D by biopharmaceutical companies; new product launches and rising acceptance of biosimilars in North America region are some of the major factors that propel the biosimilars market growth.

25 November 2020

Read

Visiongain Publishes Advanced Therapy Medicinal Products (ATMP) Market Report 2021-2031

Currently, the ATMP market is at a nascent stage and is expected to flourish during near future owing to increasing research and development activities and rising use of ATMP therapy products in treatment areas with low or no alternative treatment options support the market growth

24 November 2020

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever